cannabidiol-3-monomethyl ether has been researched along with omeprazole in 1 studies
| Studies (cannabidiol-3-monomethyl ether) | Trials (cannabidiol-3-monomethyl ether) | Recent Studies (post-2010) (cannabidiol-3-monomethyl ether) | Studies (omeprazole) | Trials (omeprazole) | Recent Studies (post-2010) (omeprazole) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 9,085 | 2,737 | 1,487 |
| Protein | Taxonomy | cannabidiol-3-monomethyl ether (IC50) | omeprazole (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 3.1448 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.28 | |
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 1.45 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 2.315 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 1.45 | |
| WD repeat-containing protein 5 | Homo sapiens (human) | 1.7 | |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | 4.6 | |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 1.7 | |
| Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, R; Okamoto, Y; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
1 other study(ies) available for cannabidiol-3-monomethyl ether and omeprazole
| Article | Year |
|---|---|
Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.
Topics: Aryl Hydrocarbon Hydroxylases; Cannabidiol; Cytochrome P-450 CYP2C19; Female; Humans; Inhibitory Concentration 50; Kinetics; Male; Microsomes, Liver; Omeprazole; Recombinant Proteins; Structure-Activity Relationship | 2013 |